Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome

Xavier Blanchet, Katja Cesarek, Johanna Brandt, Heiko Herwald, Daniel Teupser, Helmut Kuechenhoff, Ela Karshovska, Sebastian F. Mause, Wolfgang Siess, Hermann Wasmuth, Oliver Soehnlein, Rory R. Koenen, Christian Weber, Philipp von Hundelshausen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Activated platelets and neutrophils exacerbate atherosclerosis. Platelets release the chemokines CXCL4, CXCL4L1 and CCL5, whereas myeloperoxidase (MPO) and azurocidin are neutrophil-derived. We investigated whether plasma levels of these platelet and neutrophil mediators are affected by the acute coronary syndrome (ACS), its medical treatment, concomitant clinical or laboratory parameters, and predictive for the progression of coronary artery disease (CAD). In an observational study, the association of various factors with plasma concentrations of platelet chemokines and neutrophil mediators in 204 patients, either upon admission with ACS and 6 hours later or without ACS or CAD, was determined by multiple linear regression. Mediator release was further analysed after activation of blood with ACS-associated triggers such as plaque material. CXCL4, CXCL4L1, CCL5, MPO and azurocidin levels were elevated in ACS. CXCL4 and CCL5 but not CXCL4L1 or MPO were associated with platelet counts and CRP. CXCL4 (in association with heparin treatment) and MPO declined over 6 hours during ACS. Elevated CCL5 was associated with a progression of CAD. Incubating blood with plaque material, PAR1 and PAR4 activation induced a marked release of CXCL4 and CCL5, whereas CXCL4L1 and MPO were hardly or not altered. Platelet chemokines and neutrophil products are concomitantly elevated in ACS and differentially modulated by heparin treatment. CCL5 levels during ACS predict a progression of preexisting CAD. Platelet-derived products appear to dominate the inflammatory response during ACS, adding to the emerging evidence that ACS per se may promote vascular inflammation.
Original languageEnglish
Pages (from-to)1277-1287
JournalThrombosis and Haemostasis
Issue number6
Publication statusPublished - Dec 2014


  • Acute coronary syndrome
  • atherosclerosis
  • chemokines
  • platelets
  • neutrophils


Dive into the research topics of 'Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome'. Together they form a unique fingerprint.

Cite this